Oklahoma Administrative Code › Title 442 - Oklahoma Medical Marijuana Authority › Chapter 10 - Medical Marijuana Regulations › Subchapter 8 - Laboratory Testing › Section 442:10-8-6.1 - Laboratory standardization recommendations for testing standards and thresholds

Current through Vol. 41, No. 20, July 1, 2024
(a)
Laboratory standardization recommendations.
Beginning June 1,
				2024, medical marijuana testing laboratories renewing their medical marijuana
				business license shall be subject to and comply with the following rules
				relating to the testing of medical marijuana, medical marijuana concentrate,
				and medical marijuana products. The refusal or failure of a medical marijuana
				testing laboratory licensee to comply with these rules relating to laboratory
				standards and testing procedures shall result in the permanent revocation of
				the medical marijuana testing laboratory license.
(b)
Purpose.
To ensure the
				suitability and safety for human consumption of medical marijuana and medical
				marijuana products, growers and processors are required to test medical
				marijuana and medical marijuana products for microbials, mycotoxins, residual
				solvents, pesticides, THC and cannabinoid concentration, terpenoid type and
				concentration, heavy metals, foreign materials and filth, and water activity
				and moisture content in accordance with the following standards and thresholds.
				No laboratory may test medical marijuana without a valid, unexpired testing
				laboratory license issued by the Authority. A licensed laboratory shall only
				send samples for testing to another Oklahoma licensed laboratory.
(c)
Batches.
(1)
Batch size.
Growers shall
				separate all harvested medical marijuana into harvest batches that weigh less
				than or equal to fifteen (= 15) pounds with the exception of any plant material
				to be sold to a licensed processor for the purposes of turning the plant
				material into concentrate which may be separated into harvest batches that
				weigh less than or equal to fifty (= 50) pounds. Processors shall separate all
				medical marijuana product into production batches that contain a volume that is
				less than or equal to four (= 4) liters of liquid medical marijuana concentrate
				or that weigh less than or equal to nine (= 9) pounds for nonliquid medical
				marijuana products, and for final medical marijuana products shall contain less
				than or equal to one-thousand (= 1,000) grams of total
				delta-9-tetrahydrocannabinol ([DELTA]-9-THC).
(2)
Research and Development (R&D)
				testing.
Growers and processors may submit samples for research and
				development testing. R&D testing may be performed by a licensed laboratory
				in accordance with these Rules:
(A) Passing
				R&D test results. If a sample submitted to a laboratory passes a R&D
				test, it shall not constitute a pass for the purposes of compliance with
				required testing under OAC
				442:10-8-1(i);
(B) Failing R&D test results. If a sample
				submitted to a laboratory fails a R&D test, laboratories shall clearly note
				in the State's inventory tracking system and on any COA created for an R&D
				sample that the test results are for R&D purposes only; and
(C) Growers and processors shall ensure that
				any R&D testing done under this subsection is appropriately documented and
				identified in the State's inventory tracking
				system.